Company Seeks To Enjoin FDA From Restricting Speech About Off-Label Uses

(September 30, 2015, 10:49 AM EDT) -- NEW YORK — On the heels of a ruling in a similar case, Pacira Pharmaceuticals Inc. on Sept. 8 filed a declaratory action seeking to enjoin the Food and Drug Administration...
To view the full article, register now.